XML 24 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 28, 2025
Sep. 29, 2024
Sep. 28, 2025
Sep. 29, 2024
CASH FLOWS (USED FOR)/PROVIDED BY OPERATING ACTIVITIES:        
Net (loss)/income $ (20,131) $ 37,572 $ (494,654) $ 25,978
Adjustments to reconcile net (loss)/income to net cash (used for)/provided by operating activities:        
Depreciation and amortization expense     103,129 99,562
Deferred and other income taxes     (37,396) (22)
Goodwill impairment 0 0 355,958 0
Other asset impairments and lease termination charges     55,941 368
Loss on disposal of property and equipment     1,466 470
(Gain)/loss on divestiture of Insomnia Cookies 0 (87,128) 11,501 (87,128)
Gain (Loss) on Sale of Properties (1,063) 0 (1,063) 0
Gain on remeasurement of equity method investment 0 (5,579) 0 (5,579)
Gain on sale-leaseback 0 0 (6,749) 0
Share-based compensation 774 9,969 8,011 24,603
Change in accounts and notes receivable allowances     1,080 433
Inventory write-off     6,418 1,731
Amortization related to settlement of interest rate swap derivatives     0 (5,910)
Other     317 263
Change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments     (15,054) (35,982)
Net cash (used for)/provided by operating activities     (11,095) 18,787
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES:        
Purchase of property and equipment     (80,844) (86,877)
Proceeds from sale-leaseback     10,882 0
Acquisition of shops and franchise rights from franchisees, net of cash acquired     0 (26,612)
Purchase of equity method investment     (2,998) (3,506)
Net proceeds from divestiture of Insomnia Cookies     75,000 117,646
Principal payment received from loan to Insomnia Cookies     0 45,000
Principal payments received from loans to franchisees     1,202 0
Disbursement for loan receivable     0 (1,086)
Other investing activities     177 180
Net cash provided by investing activities     3,419 44,745
CASH FLOWS PROVIDED BY/(USED FOR) FINANCING ACTIVITIES:        
Proceeds from the issuance of debt     661,026 490,000
Repayment of long-term debt and lease obligations     (606,581) (545,692)
Payment of financing costs     (825) 0
Proceeds from structured payables     242,350 298,551
Payments on structured payables     (270,418) (264,346)
Capital contribution by shareholders, net of loans issued     0 919
Proceeds from sale of noncontrolling interest in subsidiary     0 364
Distribution to shareholders     (11,934) (17,743)
Payments for repurchase and retirement of common stock     (1,184) (4,366)
Distribution to noncontrolling interest     (36) (35,035)
Net cash provided by/(used for) financing activities     12,398 (77,348)
Effect of exchange rate changes on cash, cash equivalents and restricted cash     (2,885) 1,086
Net increase/(decrease) in cash, cash equivalents and restricted cash     1,837 (12,730)
Cash, cash equivalents and restricted cash at beginning of period     29,315 38,614
Cash, cash equivalents and restricted cash at end of period 31,152 25,884 31,152 25,884
Supplemental schedule of non-cash investing and financing activities:        
(Decrease)/increase in accrual for property and equipment     (12,363) 12,362
Accrual for distribution to shareholders     0 (5,943)
Reconciliation of cash, cash equivalents and restricted cash at end of period:        
Cash and cash equivalents 30,707 25,410 30,707 25,410
Restricted cash 445 474 445 474
Total cash, cash equivalents and restricted cash $ 31,152 $ 25,884 $ 31,152 $ 25,884